Actual Medicinal Product (AMP) Actos 30mg tablets (Mawdsley-Brooks & Company Ltd)
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Protect from light Moisture sensitive medicine. Store in airtight (sealed) MCA No stability data in MCAs available
- Provenance
-
This recommendation is based on the products pioglitazone 30mg tablets (Sandoz Limited) and pioglitazone 30mg tablets (Brown & Burk UK Ltd)
- Generic
- Pioglitazone
- Formulation
- Pioglitazone 30mg tablets
-
Pioglitazone
-
Pioglitazone 30mg tablets
-
Actos 30mg tablets (Mawdsley-Brooks & Company Ltd)
-
-